Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014435 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014436 |
| CAS No | NA |
| Mol.F. | C24H25Cl2N5O4 |
| Mol.Wt. | 518.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014437 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 282.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014438 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.56 |
| INV STATUS | In Stock |
| CAT No | SRC-N014439 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014440 |
| CAS No | NA |
| Mol.F. | C21H19N3O3 |
| Mol.Wt. | 361.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014441 |
| CAS No | NA |
| Mol.F. | C35H29N3O5 |
| Mol.Wt. | 571.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014442 |
| CAS No | 77400-46-5 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.17 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014443 |
| CAS No | NA |
| Mol.F. | C16H22N2O5 |
| Mol.Wt. | 322.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014444 |
| CAS No | NA |
| Mol.F. | C31H41N3O8 |
| Mol.Wt. | 583.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014445 |
| CAS No | NA |
| Mol.F. | C18H20N4O2 |
| Mol.Wt. | 324.38 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014446 |
| CAS No | NA |
| Mol.F. | C28H30N4O7 |
| Mol.Wt. | 534.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014447 |
| CAS No | NA |
| Mol.F. | C10H14N4O6 |
| Mol.Wt. | 286.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014448 |
| CAS No | NA |
| Mol.F. | C17H14BrF2N5O4 |
| Mol.Wt. | 470.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014449 |
| CAS No | NA |
| Mol.F. | C12H14N4O3S |
| Mol.Wt. | 294.33 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014450 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |